Clinical and Applied Thrombosis/Hemostasis · 2016 · 34 citations · 20 references
MedicineCardiologyClinical CardiologyInterventional CardiologyOutcomes ResearchAcute Coronary Syndrome InterventionCardiovascular DiseaseClinical Outcomes After Percutaneous Coronary InterventionIn-hospital MortalityMyocardial Infarction Risk StratificationPercutaneous Coronary Intervention Care
CHA 2 DS 2 -VASc score includes similar risk factors for coronary artery disease. We hypothesized that admission CHA 2 DS 2 -VASc score might be predictive of adverse clinical outcomes for patients with ST-segment elevation myocardial infarction (STEMI) who were undergoing primary percutaneous coronary intervention. A total of 647 patients with STEMI enrolled in this study. The study population was divided into 2 groups according to their admission CHA 2 DS 2 -VASc score. The low group (n = 521) was defined as CHA 2 DS 2 -VASc score ≤2, and the high group (n = 126) was defined as CHA 2 DS 2 -VASc score >2. Patients in the high group had significantly higher incidence of in-hospital cardiovascular mortality (8.7% vs 1.9%; P < .001). Long-term mortality was significantly frequent in the high group (13.4% vs 3.6%, P < .001). Hypertension, admission CHA 2 DS 2 -VASc score, and Killip class >1 were independent predictors of long-term mortality. Admission CHA2DS2-VASc score >2 was identified as an effective cutoff point for long-term mortality (area under curve = 0.821; 95% confidence interval: 0.76-0.89; P < .001). CHA 2 DS 2 -VASc score is a simple, very useful, easily remembered bedside score for predicting in-hospital and long-term adverse clinical outcomes in STEMI.
20
James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text